Laboratory Products
Mapping Pain Pathways in the CNS
Mar 02 2012
Integrated DNA Technologies (IDT) distributes the highly informative newsletter, DECODED. In this quarter’s edition the work carried out by Dr Philippe Sarret and colleagues is discussed in detail.
Sarret’s laboratory is based at the Université de Sherbrooke, Quebec, Canada, where researchers are investigating novel ways to develop analgesics and are the first to attempt RNA interference (RNAi) via direct in vivo targeting of genes expressed in the central nervous system (CNS). Using IDT’s Dicer-substrate RNAs (DsiRNAs), the team is specifically targeting pain-modulating pathways such as that mediated by the nueropeptide, neurotensin.
DsiRNAs have increased potency compared to traditional small interfering RNAs, achieving sustained knockdown at subnanomolar concentrations. Full details of this research can be found by downloading the latest edition of IDT’s DECODED newsletter, which also provides technology overviews, interviews, and procedural recommendations relating to oligonucleotides and their applications.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria